ENDOBARIHEART STUDY
Key facts
- Where
- Cotignola, ItalySee the site
Where in Italy
- Maria Cecilia HospitalCotignola, ItalyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Maria Cecilia Hospital
- Trial code
- NCT07847307
- Record updated
- 9 October 2026
- Original description
The primary outcome of this study is to evaluate changes in cardiovascular risk after endoscopic sleeve gastroplasty (ESG) in patients at high cardiovascular risk, using the SCORE2 ( Systematic COronary Risk Evaluation 2) and SCORE2-OP ( Systematic COronary Risk Evaluation 2 Older Persons) risk scores, which estimate the risk of having a cardiovascular event.Read full original descriptionShow less
CARDIOVASCULAR RISK PROFILE IN HIGH CARDIOVASCULAR RISK OBESE PATIENTS BEFORE AND AFTER ANDOSCOPIC SLEEVE GASTROPLASTY: A PILOT STUDY
The primary outcome of this study is to evaluate changes in cardiovascular risk after endoscopic sleeve gastroplasty (ESG) in patients at high cardiovascular risk, using the SCORE2 ( Systematic COronary Risk Evaluation 2) and SCORE2-OP ( Systematic COronary Risk Evaluation 2 Older Persons) risk scores, which estimate the risk of having a cardiovascular event.
Inclusion: informed consent; obesity or overweight; atherosclerotic cardiovascular disease; type 1 or type 2 diabetes mellitus; hypercholesterolemia or severe dyslipidemia; evidence of subclinical atherosclerosis.
Exclusion: anticoagulant therapy; chronic treatment with immunosuppressants/immunomodulators; chronic inflammatory diseases; active viral or bacterial infections; severe chronic kidney failure; active malignancy; severe anaemia or severe coagulopathy; pregnancy.